4//SEC Filing
Manting Erik 4
Accession 0001104659-23-062816
CIK 0001829635other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 8:09 PM ET
Size
5.4 KB
Accession
0001104659-23-062816
Insider Transaction Report
Form 4
Manting Erik
Director
Transactions
- Award
Stock Option (right to buy)
2023-05-19+45,000→ 45,000 totalExercise: $0.28Exp: 2033-05-18→ Common Stock (45,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest and become exercisable in full on December 31, 2023, subject to the Reporting Person's continued service at such time.
Documents
Issuer
Transcode Therapeutics, Inc.
CIK 0001829635
Entity typeother
Related Parties
1- filerCIK 0001856180
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 8:09 PM ET
- Size
- 5.4 KB